AI assistant
Sending…
RESMED INC — Director's Dealing 2013
Feb 27, 2013
30071_dirs_2013-02-27_6d750e9f-656b-4ff3-a1f9-ee9bba84225d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-02-25
Reporting Person: Reiser Anne (President - ResMed Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-25 | ResMed Common Stock | M | 10000 | $24.570 | Acquired | 46803.142 | Direct |
| 2013-02-25 | ResMed Common Stock | S | 10000 | $43.20 | Disposed | 36803.142 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-25 | ResMed Stock Options | $24.570 | M | 10000 | Disposed | 2013-11-24 | ResMed Common Stock (10000) | Direct |
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29